Bai, L., Chen, F., Xu, J., Cui, J. (2025). TLR9 agonists as a potential therapeutic option for B-ALL patients with low P53 expression.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6526